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Metallothioneins are peculiar cysteine rich, heat resistant, small cellular plasma proteins expressed through almost all 
life forms. The currently established biological functions of metallothioneins are the homeostasis of essential metals and 
protection against toxic transitional metals (TM) alongside defence from oxidative stress by direct scavenging of reactive 
oxygen and nitrogen species (ROS and RNS). In mammals, among the four main evolutionary conserved forms, only the 
ubiquitously expressed metallothionein 1 and 2 (here abbreviated as MT) are inducible by TM, oxidative stress, 
glucocorticoids and starvation among various other stimuli. However, more than sixty years after being discovered, 
metallothioneins still bear unresolved issues about their possible physiological function and regulation. The biological 
function of MTs has still not been associated with the in vitro-demonstrated capacity of MT interaction with cellular 
molecules glutathione (GSH) or adenosine triphosphate (ATP), or with the possibility of direct iron-MT binding in the 
reducing intracellular environment of some organelles, e.g. lysosomes. Iron as the most abundant cellular TM is also one 
of the main physiological sources of ROS. Moreover, iron exhibits strain, sex and age differences that reflected ROS 
generation and MT induction in (patho)physiology and toxicology studies. A recent study showed that iron sex differences 
follows expression of both ferritin and MT leading to wide implications from essential TM interconnectivity to aging. 
This review places emphasis on biochemically proven but physiologically ignored interactions of MT with iron to stimulate 
advanced research for establishing a wide frame of the biological roles of MTs important for health and longevity.
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GENERAL INTRODUCTION TO 
VERTEBRATE METALLOTHIONEINS
In the six decades of research since metallothioneins 
were first isolated (1), over 12,500 biomedical publications 
have been indexed in PubMed (October 2019) about these 
atypical metal binding proteins, and almost half as many 
more if other scientific databases are considered (2). 
Structurally, mammalian metallothioneins are heat 
resistant, small (about 6–7 kDa), dumbbell shaped proteins 
with the ability of its N-terminal beta domain to bind labile 
and easily exchangeable three divalent (or more monovalent) 
TMs through 9 cysteines (Cys) and of its C-terminal alpha 
domain to bind more stable four divalent TMs coordinated 
with 11 Cys, whereas cleft-formed through a linker region 
between two domains can potentially accommodate 
phosphate, GSH or ATP molecules (Figure 1) (2-8). From 
around 60 amino acids (AA) in mammalian metallothioneins, 
one third are Cys AA and a significant part are made of 
conserved lysine and serine without the presence of any 
aromatic or histidine AA. Mammals have four main forms 
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or family members of metallothioneins among which MT1 
and MT2 (MT), of primary concern in this review, are 
ubiquitously present because of their cellular protective 
task and the fact that their expression is induced by various 
stresses, e.g. heat shock, glucocorticoids, oxidative stress, 
calorie restriction (CR) as well as with a wide range of TMs. 
Metallothionein 3 (MT3) has a specific function in the 
central nervous system (CNS) as a growth inhibitor factor 
(GIF), while metallothionein 4 (MT4) is found only in 
squamous epithelial cells (2-4).
Functionally, MTs are involved in the protection against 
oxidative stress as well as in the homeostasis of essential 
TMs with stress placed on zinc (Zn) and copper (Cu). 
Additional metal sequestration and defence against toxic 
TMs, e.g. cadmium (Cd), mercury (Hg), silver (Ag), 
platinum (Pt) and others such as lead (Pb) and metalloids 
such as arsenic (As), are accompanied by protection against 
oxidative stress through direct ROS and RNS binding (9-
12). The biochemical work done thus far has revealed 
non-cooperative binding of various metals to MT according 
to their thiol affinity including iron (Fe) (10). This review 
emphasizes the possible biological role of iron-MT binding 
from in vitro findings through the 1980s, which were largely 
ignored despite the detection of iron in the first MT isolate 
by Vallee (1). Throughout evolution, we are bounded to the 
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trio of transition metals iron, zinc and copper that seems to 
reflect in metallothionein’s properties and their presence in 
today’s organisms (2, 4)
No MT is indispensable for life, so after knocking out 
MT1 and/or MT2, experimental animals (MT null) are 
viable but exceedingly sensitive to various stresses and 
prone to developing certain unexpected consequences of 
metabolic impairment and shorter lifespan, together with 
ionizing and UV radiation sensitivity. Conversely, animals 
that overexpress MT do have higher resistance to various 
stresses and live a longer and healthier life (13-15).
The aim of this review was to motivate researchers in 
the field for more integrated and/or system biology-oriented 
work on the involvement of MTs in the fine-tuning of 
essential TMs as it is well-known that zinc is necessary for 
antioxidative and anti-inflammatory action together with 
Fenton reactive copper and iron that jointly affect 
metabolism regulation throughout aging (16, 17).
OXIDATIVE STRESS AND TMs
The relevant literature comprises volumes of studies on 
antioxidative actions (16-19). However, it is not so often 
emphasized that iron, the most abundant TM in the 
organism, is a strong and potent generator of physiological 
oxidative stress, through valence change according to the 
environment from reduced divalent ferrous ion (Fe2+) to 
oxidized ferric ions (Fe3+). By releasing an electron in the 
presence of hydrogen peroxide (H2O2), ferrous ion initiates 
a Fenton reaction of hydroxide radical (OH-.) generation 
that modifies all biomolecules. Despite being mainly 
considered through oxygen delivery via haemoglobin in 
erythrocytes and myoglobin in muscles, iron should also 
be viewed through the lens of its abundance in the cells of 
various organs and importance in all biological processes 
as in the mitochondrial electron transport chain together 
with its role in enzyme functions, e.g. catalase (CAT), and 
structure, e.g. S-Fe clusters in ribonucleotide reductase 
(RNR). Specificity in iron turnover throughout the 
organism, organs, and cells resides in the regulated 
mechanisms of Fe accumulation without any processes of 
active excretions. Cellular protection from the negative 
impact of Fe relies on a very small group of potential 
cytosolic iron chaperones together with the great storage 
capacity of the ferritin nanocage and may include the 
possibility of Fe-MT interaction and iron scavenging in 
organelles. The mentioned roles in various metabolic 
functions make iron an essential TM in all organisms, while 
both its deficiency and overload may lead to serious health 
problems (17).
When describing the function and structure of various 
metalloproteins, with a few exceptions, focus is often placed 
on Zn as the second most abundant TM in the organism. 
Zinc is of immense importance for about 3,000 proteins 
because of its redox inertia and importance for the structure 
and function of enzymes and transcription factors. Zn is 
known to protect from various kinds of stress, as 
demonstrated by numerous studies in humans and animal 
models. Furthermore, the upregulation of MTs fulfils Zn’s 
antioxidant function and together with anti-inflammatory 
and other positive and protective roles, it is undoubtedly 
important for health and longevity (16, 19). 
The third essential TM present in organisms in abundance 
is Cu, which as a Fenton reactive metal must also be tightly 
controlled mainly by MTs and a few chaperones in the cell. 
An important role in the regulation of copper levels is also 
attributed to the copper plasma carrier ceruloplasmin, a 
multicopper ferroxidase that together with another copper 
enzyme hephaestin is involved in the iron transport 
metabolism (17). Other TMs that belong to trace or ultra-trace 
elements in the organism are present at concentrations a few 
orders of magnitude lower and have a place in the 
metalloprotein networks that include MTs (20).
MEMBRANE TRANSPORT OF IRON, ZINC, 
AND COPPER
Membranes of cells and organelles are barriers for TMs. 
Currently, the transport of all essential TMs is covered either 
through the general divalent metal transporter (DMT1; 
Solute carrier transporter, SLC11A2) or through active 
gastrointestinal ATP7A and hepatic ATP7B transporters for 
copper and ZnT (SLC30A) and ZIP (SLC39A) transporters 
Figure 1 Molecular structures of MT (4mt2, PDB), ATP, and GSH. 
Using the Discovery Studio 2019 Client (BioVia/Accelrys, San 
Diego, USA), the superposition of real conformations of whole 
MT and molecules ATP and GSH was performed. This showed a 
considerable possibility of binding into the interdomain cleft of 
MT with a probability of pH dependence that influenced the 
intradomain linker region (68). N and C terminal domains are 
shown with their metal binding properties: M – transition metal 
(divalent), S – thiol moiety of cysteine (gold yellow colour)
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for zinc and iron to the only cellular iron export protein 
ferroportin FNP1 (SLC40A1) (20). 
Many of the reviews published thus far have described 
in detail a vast amount of knowledge, thereby creating a 
complex picture of the transport mechanism for each TM 
to the point of its autoregulation through feedback loops 
that are still to be discovered (21-26). After years of research 
on zinc transporters, two large families of divalent metals 
emerged; nine ZnT family members that facilitate entry into 
the cytosol and fourteen ZIP family members that enable 
exit. This excessive number of zinc transporters may be the 
reason why MT null animals can be viable, as some of the 
transporters are essential for embryonal development 
onward. Both types of transporters carry not only Zn, but 
also cadmium (Cd) and manganese (Mn), while ZIP 
members can transport Fe as well. Some members of the 
ZIP family, named after the zinc and iron regulated transport 
proteins found in plants (Zrt/Irt-like proteins), do have a 
relevant physiological role in non-transferrin bound iron 
(NTBI) transport and current research into these is very 
active. 
CELLULAR DISTRIBUTION OF MTs
MTs as TM chaperones and ROS/RNS quenchers play 
an important role in cellular metabolic tangled webs. They, 
however, are not located exclusively in the cytosol (2-4, 
9-12); MT presence has often been observed in the 
mitochondria and nucleus of proliferative cells and within 
lysosomes. Furthermore, each cellular compartment has its 
specificity regarding function and microenvironmental 
conditions, especially proton abundance that defines pH 
(27).
The cytosol can be regarded as a pH neutral main milieu 
for all organelles, proteins, and other components that 
interact with TMs. This enables metals to be stored, utilized 
or redistributed, in parallel with the dynamic level of ATP 
and GSH concentrations that regulate signalling of a cell’s 
energy and oxidative status, respectively. 
Mitochondria, as the main energy supply compartment, 
are also constant producers of ROS in the form of 
superoxide radicals (O2
-) that are reduced to H2O2 through 
superoxide dismutase (SOD) activity. This organelle is very 
rich in Fe enzymes under oxidative conditions, and has a 
specific compartmentalization and inner structure with two 
levels of proton concentrations. The inside of the 
mitochondrial matrix is an alkaline environment suitable 
for citric acid cycle and hem synthesis, whereas the 
intermembrane space has an only slightly lower pH than 
the cytosol. Mitochondria are also involved in the process 
of programmed cell death (PCD) by mediating classical 
intrinsic pathways of apoptosis with cytochrome c release 
and caspase activation. However, under certain conditions 
of metabolic disturbance that liberates too much iron in the 
presence of H2O2 consequently generating lipid peroxides, 
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mitochondria can also be involved in another pathway of 
non-apoptotic regulated cell death (RCD) called ferroptosis 
(28). MT has a proven protective role that can be primarily 
linked to the prevention of either the causes or consequences 
of ROS/RNS action (2-4), but whether MT’s anti-apoptotic 
and anti-ferroptotic role can also involve the direct binding 
of free Fe, e.g. from lysosomes or damaged mitochondria 
is still an open question. 
The nucleus is a cellular compartment where MTs can 
mostly be found during the cellular proliferative phase, 
when MTs serve probably as donors of TMs, especially of 
Zn to transcription factors (steroid hormone receptors and 
zinc finger transcription factors), but also possibly as direct 
ROS/RNS scavengers.
Lysosomes are main organelles where degradation of 
cellular MT protein occurs through acid proteases 
cathepsins when TM-MT complexes are much more 
resistant to degradation than MT without a bound TM 
(apothionein). That degradation scenario is unusual for free 
cellular cytoplasmic proteins, as it largely does go through 
the proteasomal system (29).
A cellular recycling process through lysosomal 
degradation of organelles and proteins rich in Fe make one 
unexpected interaction milieu of MTs and Fe (30, 31), which 
attracted the attention of researchers in the last decades. 
The findings by Baird et al. (31) suggest that the acidic 
environment of lysosomes is a surrounding that can 
stimulate MT release of Zn or Cu while facilitating Fe-MT 
binding and thereby protecting organelles from ROS 
generation from liberated reduced Fe in the presence of 
H2O2. Fe endosomal/lysosomal entrance also occurs with 
transferrin-Fe (TfFe) cellular arrival throughout receptor-
mediated endocytosis (RME), autophagocyted mitochondria, 
and other organelles as well as through a special autophagic 
process called ferritinophagy of Fe stored in ferritin, all of 
which use endosomes through lysosome compartments for 
releasing and mobilizing Fe, and consequently creating a 
cytosolic liable iron pool (LIP) (17, 30, 31). In this process 
MTs from cytosol enter the lysosome by microautophagy 
where they acquire higher affinity for reduced Fe and 
participate in its sequestration, preventing uncontrolled 
Fenton reactions and Fe release through a Zip8 or DMT1 
into the cytosol and averting the overall LIP increase. 
In relation to interference with normal physiology, the 
example of the well-studied Cd toxicity shows that 
exogenous toxic TM can induce MTs and generate oxidative 
stress. As Cd is not a redox reactive (Fenton active) TM, it 
can enter the cell through molecular mimicry to interfere 
with described endocytic pathways and liberate Fe which 
triggers oxidative damage (10).
Recently, the role of lysosomes in the aging theories 
also highlighted the importance of iron in autophagocytic 
pathways through an increase in LIP or undegraded protein 
accumulation and overall ROS generation (32, 33).
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DIRECT INTERACTION OF IRON AND MTs
The established function of Zn and Cu homeostasis in 
the organism is based on the capacity of inducible MTs to 
bind various TMs with or without a possible biological 
function, on the basis of their –SH affinity, ion radius, orbital 
conformation and probably depending on environmental 
pH (2-4, 9-12). With this in mind, the potential of Fe-MT 
binding that may occur in acidic environments in lysosomes 
and inner mitochondrial membrane space is largely 
underestimated. Despite the fact that Fe was found in the 
first MT isolates, Fe went “under the radar” in MT research 
soon afterwards (1, 10, 12). A possible cause for this may 
be a coincidental technical finding from our group that most 
Fe-MT interactions involve cellular organelles and that 
fractions are mainly lost during protein purification through 
high-speed centrifugations.
From a historical perspective, the coincidence that 
Yutaka Kojima, who was an appreciated and a long term 
collaborator of Vallee and Kagi, the “fathers” of MTs, shares 
his surname with Nakao Kojima, the author of the first 
negative in vitro Fe-MT binding results (34), might have 
had at least some measure of influence on other researchers 
taking Nakao Kojima’s findings “for granted” and not 
testing the validity of these results further. Only three years 
later, Good and Vasak (35) published positive in vitro Fe-
MT binding results starting from an acid to alkali 
environment with a subsequent multifaceted analysis of the 
formation, stability, and structure of the Fe-MT complex 
(36, 37). However, the biological relevance of these results 
was completely neglected in the MT-related papers that 
followed (3, 9), even in spite of indicative in vivo results 
observed in an avian model (39). One reason why MTs were 
sidestepped may be that another ubiquitously abundant and 
physiologically relevant Fe-binding and storage complex 
- ferritin – had already been isolated from the cytosol (30) 
and received more attention.
In vitro studies of Fe-MT binding sparsely continued 
throughout the 1990s among which Kennedy et al. (39) 
revealed electron spin resonance (ESR) spectroscopy 
findings that nitric oxide (NO) removes Zn from MT and 
interacts with freshly bound Fe-MT, while Ding et al. (40) 
repeated previous studies of Fe-MT binding in yeast MT. 
The only recent study in the 21st century explored the 
reduction potential of the tetranuclear iron core in the 
synthetic alpha domain of MTs in an alkaline pH 
environment. This was biochemically interesting, but 
physiologically not as relevant mainly because of the high 
pH in the experiments (41).
Another two studies on unexpected iron MT interaction 
(42, 43) investigated cytosolic ferritin direct contact with 
MTs where both Zn and Fe were released and this might 
well be extremely significant for MT, Zn, and Fe physiology.
REGULATION OF MT EXPRESSION
The TM driven pathway of MT expression regulation 
is already textbook knowledge; it goes through direct 
induction when another TM has higher affinity for MT 
binding and easily releases Zn into the cytosol. Released 
Zn binds to the metal transcription factor (MTF1) that, once 
it is activated, starts transcription through the presence of 
a metal response element (MRE) in the MT promotor 
region. Nascent MT mRNA expression is followed by 
translation to proteins that may increase several-fold in the 
abundance of mRNA templates. Oxidative stress and the 
glucocorticoid-driven pathway can also directly induce MT 
expression through respective antioxidative and 
glucocorticoid response elements (ARE and GRE) in the 
promotor region of MT genes (2-4, 9-12, 44). Noteworthy 
of mentioning is the fact that ferritin can be, among other 
protective metalloproteins, also induced with oxidative 
stress through common transcription factor NRF2 (nuclear 
factor erythroid 2-related factor 2), which acts through the 
ARE region in the promoter making these two metal binding 
proteins among the first line of antioxidant cellular defence 
(30, 44). Of particular note is the information that specific 
RCD ferroptosis induction through sorafenib interference 
with cysteine transport for GSH synthesis emerged as a side 
effect in recent studies involving this antineoplastic multiple 
kinase inhibitor’s mode of action in hepatocellular 
carcinoma (HCC). HCC cells can escape ferroptotic death 
and become resistant to sorafenib by inducing specific 
isoform MT-1G and possible other members of the MT 
family through the action of NRF2/ARE binding resulting 
in consequent ROS scavenging, which for now seems to be 
without changes in free iron abundance (28, 44, 45).
Furthermore, from the gene regulation point of view, 
in vitro studies have unexpectedly shown that the GRE 
present in an MT promoter region can be used by 
progesterone sex steroid hormone receptors (46). That may 
be one of the pathways which affect in vivo physiological 
sex differences in the abundance of MT expression that 
follows sex differences in TM, especially in Fe (47, 48). 
The question of sex steroid hormone MT regulation is still 
unresolved. Much confusion has stemmed from two decades 
of Cd toxicity studies where protection was achieved 
through MT upregulation following any steroid treatment 
in rodents. Steroid hormone regulation influences the 
response to various inducers, not only to toxic TMs that 
have shown different effects between sexes and, moreover, 
between strains (49). Again, studies on sex differences that 
analysed Fe, ferritin, and MT and had similar findings 
suggest that there is a possibility that a different genetic 
background, which determines iron accumulation pathways 
including sex differences, is present in different mammals 
and even animal strains. This was supported by findings of 
Hahn et al. (50) in mouse liver and is most likely responsible 
for the above mentioned discrepancies reported in the 
relevant literature.
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Although physiologically positive effects of missing 
male sex hormones and negative effects of missing female 
sex hormones in MT expression and iron liver accumulation 
have been observed, immediate causes for these sex 
differences have not been established (48). One explanation 
could be that MT expression respond to oxidative stress 
and simply follows the Fe accumulation (48, 51) that is 
regulated by the liver hormone hepcidin under steroid 
hormone control (52, 53). Consequently, MT sex differences 
can be directly linked to Fe, through Fe-MT binding during 
lysosomal degradation and TM exchange that releases Zn 
for MTF-1 activation and MT expression, or indirectly, 
through LIP that causes oxidative stress pursued by the 
induction of MT expression but also of ferritin for iron 
storage, which makes these two proteins interdependent.
GENETICALLY MODIFIED ANIMALS AND 
AGING
As described in a detailed review by Mocchegiani (14), 
the difference between MT transgenic and null animals 
indicates that MT fine tuning is necessary for longevity (15, 
54-56). Among other considerations, the review stated that 
the observed anti-aging effect of upregulated MTs can be 
connected to factors so obvious as oxidative stress 
regulation and higher Zn accumulation/storage capacity 
that is necessary for all aspect of health, considering Zn 
antioxidant and anti-inflammatory function, but with the 
issue of the bioavailability of zinc when MT is high (14, 
16, 19). Findings in MT null animals suggest that MTs are 
generally not necessary for the overall Zn metabolism that 
is possibly mediated by many redundant transport 
mechanisms. However, Zn is necessary for the MT 
metabolism, and their delicate mutual relationship is 
certainly among those reflected in the benefits that 
transgenic animals have and problems during the lifetime 
of MT null animals (54-56).
None of the existing literature sources mentions the 
possibility that an abundance of MT in transgenic animals 
may serve as protection from free Fe.
FURTHER CONSIDERATIONS
Essential TMs are inevitably interconnected and MTs 
may be the common binding proteins for their fine tuning. 
However, what is currently absent is a parallel comparison 
of changes of all three essential TMs together with their 
specific and common proteins for transport, regulation, 
carriers, and storage to firmly establish every possible 
interrelation (22).
The concept that GSH abundance is probably the main 
chaperon of iron in LIP, and a direct association between 
GSH and iron metabolism most visible in the process of 
RCD ferroptosis opens a wider perspective from both the 
physiological and toxicological points of view (28, 45, 57). 
Biochemical in vitro studies (6, 58) have mainly considered 
Zn-regulated release from MTs depending on reduced vs 
oxidised GSH in that process.
Recent data pointed out sex differences even in 
constitutive autophagy (59) that includes ferritinophagy, as 
a special autophagy form of ferritin degradation, through 
nuclear receptor coactivator 4 (NCOA4, known as androgen 
receptor-specific coactivator ARA70) that directly or 
through protein interaction may be dependent on steroid 
hormones (60). Also, ferritinophagy may as well as 
autophagy, if not regulated and coordinated with protective 
mechanisms that involve GPX4 activity through use of 
GSH, lead to iron-mediated ROS induction that oxidizes 
lipids and causes ferroptosis as a form of non-apoptotic 
RCD (28, 45).
Moreover, Fe is not the only TM that has the ability of 
being stored in a ferritin multisubunit nanocage; others do 
as well, including essential and toxic metals (61), which is 
why the two metalloproteins, ferritin and MT, should be 
considered together. Additional indirect links of Fe and Zn 
metabolism that may be finely tuned by MTs are confirmed 
by transcription factor MTF1, indispensable to an organism, 
which regulates the transcription of the cellular Fe-export 
protein FNP1 and the plasma Fe transport protein transferrin 
(Tf), as well as other  TM-regulating proteins, involved in 
Fe, Zn, and Cu homeostasis (62).
At the cellular biochemical fine tuning level, it seems 
that apart from the presence of ferritin storage, easily 
upregulated MTs may be one of the crucial small 
ubiquitously abundant proteins that protect cells against 
highly reactive Fe ions either just as oxidative quenchers 
or with an additional role by directly scavenging iron in 
lysosomes and mitochondria (31).
Moreover, MT1 does make a response to iron deficiency 
in the blood and tissue connecting MTs not only to storage/
scavenge but also to erythropoiesis that has strong 
opposition/competition from the involvement of other 
proteins (63, 64). Nonetheless, although the above 
mentioned sex difference in Fe, connected to ferritin 
expression (65) have been known for decades, their 
consequences also have long been ignored and have 
undoubtedly influenced physiological and very probably 
toxicological studies (49) together with analyses of MT 
expression.
This review indicates that Fe (30-33, 35–40), ATP, and 
GSH (5-8, 58) act together with MTs alongside established 
protein interactions with emphasis on ferritin (42, 43, 58, 
66) and that this takes place with the influence of steroid 
hormones in the background (Figure 2). Even as a study by 
Zangger and Armitage (67) which failed to prove MT and 
ATP interactions nevertheless revealed changes in pH when 
ATP is added to the reaction. These changes yielded a result 
regarding oxidative and pH dependence of interactions that 
was confirmed in a later study (8). Furthermore, there is a 
probability that in vivo accumulation of phosphate by aging 
may disturb ATP/GSH-MT binding position and promote 
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multimerization/crystallization of MTs that may be involved 
in lipofuscin/protein aggregate formation and the pathology 
of neurodegenerative diseases (32, 33, 58, 68, 69).
CONCLUDING REMARKS
This review was motivated by the necessity for an in 
vitro and in vivo revalidation of the biologically important 
regulation and interactions of MT with iron. Therefore, we 
underline that each separate cell organelle with a distinctive 
microenvironment and discrete ATP and GSH content 
contains MTs with possible different TMs bound to them 
for exchange within other compartments. Emphasis should 
be placed not only on MT’s ROS/RNS scavenging function, 
but also on the possibility of direct MT interaction with 
metals, including iron, ATP, and GSH in different cellular 
compartments especially mitochondria and lysosomes. TM 
abundance and distribution depends on physiological 
conditions such as sex differences and possibly even the 
female sex cycle regulated by steroid hormones. Sex 
differences in Fenton reactive TM are under regulatory 
mechanisms that also drive MT expression. Zinc as a sex-
independent and Fenton inert TM is a highly abundant and 
indispensable regulatory and stimulatory factor for various 
proteins including MT that leads to lower oxidative stress 
and anti-inflammation processes. Furthermore, the 
possibility that MT expression can be modulated by non-
toxic Zn supplementation and influence an organism’s 
response to oxidative stress, as in Wilson’s disease (70), 
can be applied to more disorders where oxidative stress and 
metal accumulation underlie the causes and/or the 
consequences of pathology.
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Zaboravljeni partneri i regulatori funkcije inducibilnih metalotioneina
Metalotioneini su mali proteini stanične plazme specifični po zastupljenosti cisteina i otpornosti na toplinu, a izraženi su 
kroz gotovo sve oblike života. U sisavaca, među četirima glavnim evolucijski očuvanim oblicima, samo se sveprisutno 
izraženi metalotioneini 1 i 2 (u daljnjem tekstu MT) induciraju s različitim prijelaznim metalima (TM), oksidacijskim 
stresom, glukokortikoidima, gladovanjem između ostalih stimulansa. Trenutna uspostavljena uloga MT-ova u stanici je 
homeostaza esencijalnih i zaštita od toksičnih TM-ova, zajedno s obranom od oksidacijskoga stresa izravnim uklanjanjem 
reaktivnih kisikovih i dušikovih vrsta (ROS/RNS). Međutim, čak i više od šezdeset godina nakon otkrića, oko metalotioneina 
i dalje postoje neka neriješena pitanja o njihovoj funkciji i regulaciji. Naime, funkcija MT-ova još uvijek nije povezana 
s in vitro dokazanom sposobnošću vezanja MT-ova sa staničnim molekulama GSH-a ili ATP-a, zajedno s važnim procesom 
vezanja željeza MT-a u reduktivnom okolišu npr. lizosoma. Željezo kao najzastupljeniji stanični TM također je i glavni 
izvor ROS-a. Ujedno željezo pokazuje razlike između vrsta i sojeva te među spolovima i u starenju, koje mogu odražavati 
nastajanje ROS-ova i izražaj MT-ova u (pato)fiziološkim i toksikološkim istraživanjima. Promjene MT-ova koje prate 
razlike u željezu nedavno su dokazane i imaju široke implikacije od međusobne povezanosti esencijalnih TM-ova do 
starenja. Ovaj pregledni članak stavlja naglasak na biokemijski dokazane ali većinom fiziološki ignorirane interakcije in 
vitro MT-ova i željeza za poticaj naprednih istraživanja koja bi izgradila širu mrežu MT-ove biološke uloge važne za 
zdravlje i dugovječnost.
KLJUČNE RIJEČI: adenozintrifosfat; bakar; cink; feritin; glutation; oksidacijski stres; prijelazni metali; spolne razlike; 
starenje; steroidni hormoni; željezo
